Intervention Review

Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease

  1. Peter C Gøtzsche*,
  2. Helle Krogh Johansen

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 7 JUL 2010

Assessed as up-to-date: 6 JAN 2010

DOI: 10.1002/14651858.CD007851.pub2

How to Cite

Gøtzsche PC, Johansen HK. Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD007851. DOI: 10.1002/14651858.CD007851.pub2.

Author Information

  1. Rigshospitalet, The Nordic Cochrane Centre, Copenhagen, Denmark

*Peter C Gøtzsche, The Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, 3343, Copenhagen, DK-2100, Denmark. pcg@cochrane.dk.

Publication History

  1. Publication Status: Edited (no change to conclusions), comment added to review
  2. Published Online: 7 JUL 2010

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marilyn G. Foreman, Michael Campos, Juan C. Celedón, Genes and Chronic Obstructive Pulmonary Disease, Medical Clinics of North America, 2012, 96, 4, 699

    CrossRef

  2. 2
    David Armstrong, Screening: mapping medicine’s temporal spaces, Sociology of Health & Illness, 2012, 34, 2